Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory to Standard Therapies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06911333
What this trial is testing

AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor, AdultTumor, SolidSolid Tumor+4 more
Avelos Therapeutics Inc. 36
Early research (Phase 1)Study completedNCT03985072
What this trial is testing

Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor

Who this might be right for
Tumor, SolidGall Bladder CancerCervical Cancer+3 more
Andes Biotechnologies 67
Testing effectiveness (Phase 2)Study completedNCT03637556
What this trial is testing

Pilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Patients Refractory to Chelation

Who this might be right for
Thalassemia Major
DisperSol Technologies, LLC 25
Testing effectiveness (Phase 2)Looking for participantsNCT06940349
What this trial is testing

Interventional Study to Evaluate the Combination of Palbociclib + Sunitinib as a Treatment for Advanced Solid Tumors

Who this might be right for
Solid Tumors Refractory to Standard Therapy
Rabin Medical Center 100
Large-scale testing (Phase 3)Ended earlyNCT02142725
What this trial is testing

Phosphatidylcholine (LT-02) for Induction of Remission in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Dr. Falk Pharma GmbH 468
Testing effectiveness (Phase 2)Study completedNCT00967369
What this trial is testing

Combination Chemotherapy With or Without Bortezomib in Treating Patients With Classical Hodgkin Lymphoma That Has Returned or Does Not Respond to Prior Treatment.

Who this might be right for
Recurrent Classic Hodgkin LymphomaRefractory Classic Hodgkin Lymphoma
M.D. Anderson Cancer Center 20
Early research (Phase 1)Ended earlyNCT00358397
What this trial is testing

One Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy

Who this might be right for
Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06772233
What this trial is testing

Regorafenib Combined With Envafolimab for Metastatic Gastrointestinal Stromal Tumors With Kit Gene Exon 17 Mutation That Failed Standard Treatment

Who this might be right for
Metastatic Gastrointestinal Stromal Tumors (GIST)
Peking University 100
Early research (Phase 1)Study completedNCT00949949
What this trial is testing

Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy

Who this might be right for
Cholangiocarcinoma of the GallbladderLocalized Gallbladder CancerUnresectable Gallbladder Cancer+1 more
Mayo Clinic 38
Testing effectiveness (Phase 2)Study completedNCT00248365
What this trial is testing

Theralux Extracorporeal Photochemotherapy (ECP) in Patients With Extensive Chronic Graft Versus Host Disease (GvHD)

Who this might be right for
Graft vs Host Disease
Kiadis Pharma 20
Testing effectiveness (Phase 2)Looking for participantsNCT06971380
What this trial is testing

Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis

Who this might be right for
Multiple Myeloma, Refractory to Standard TreatmentMultiple Myeloma, RelapsedLight Chain Amyloidosis
Polina Stepensky 180
Large-scale testing (Phase 3)Ended earlyNCT00200070
What this trial is testing

Neurostimulation to Treat Refractory Angina Pectoris Pain

Who this might be right for
Angina Pectoris
MedtronicNeuro 228
Early research (Phase 1)Ended earlyNCT01110083
What this trial is testing

First-in-Man, Dose-escalation Trial of c-Met Kinase Inhibitor EMD 1204831 in Subjects With Advanced Solid Tumors

Who this might be right for
Solid Tumors
EMD Serono 38
Large-scale testing (Phase 3)Study completedNCT00000724
What this trial is testing

Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to Standard Therapies for Pneumocystis Carinii Pneumonia

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)WithdrawnNCT06935474
What this trial is testing

C-CAR168 CAR T Cell Therapy for Refractory Autoimmune Disease

Who this might be right for
Lupus Nephritis (LN)
AbelZeta Inc.
Testing effectiveness (Phase 2)Study completedNCT00076869
What this trial is testing

MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037)

Who this might be right for
Aspergillosis
Merck Sharp & Dohme LLC 55
Not applicableStudy completedNCT03460847
What this trial is testing

Fecal Microbiota Alterations in Steroid Refractory Active Colitis Ulcerosa

Who this might be right for
Colitis, Ulcerative
Medical University of Graz 114
Early research (Phase 1)Study completedNCT00339144
What this trial is testing

Study of Dasatinib (BMS-354825) in Patients With Solid Tumors

Who this might be right for
Tumors
Bristol-Myers Squibb 16
Testing effectiveness (Phase 2)Study completedNCT01949688
What this trial is testing

Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 or A*02-positive Advanced Solid Tumors

Who this might be right for
Solid Tumors
Shiga University 26
Early research (Phase 1)Ended earlyNCT00660036
What this trial is testing

Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
University of Pittsburgh 5
Next Page